We have just sent you an email so you can verify your account. Please check your spam or junk folder just in case it's been delivered there. EQT Private Equity and Goldman Sachs have agreed to acquire Parexel, a global clinical research organization, for $8.5 billion.
In this article
No tags related to this article.